Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
MOREPENLAB
₹60.90
₹60.56
₹62.90
₹33.05
₹65.12
Markets Today
Historical Performance
As of 13-07-2026 00:39, Morepen Laboratories Ltd. share price today is ₹0, with a change of ₹-60.96 (-100.00%) from the previous close of ₹60.96. The stock opened at ₹61.64 and traded between ₹60.56 and ₹62.9, with a total traded volume of 7959902 shares. The company has a market capitalization of ₹3340.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹65.12 and ₹33.05, respectively.
Morepen Laboratories Ltd. valuation metrics include a P/E ratio of 35.2, EPS of ₹1.73, and book value of ₹2.70. Profitability indicators show ROE of 7.61% along with a dividend yield of 0.3%. Morepen Laboratories Ltd. has reported revenue of ₹1805.69 Cr and net profit of ₹94.88 Cr.
Morepen Laboratories Ltd. technical indicators include Day RSI at 66.84, Day MFI at 81.67, Day ADX at 45.02. Additional indicators include Commodity Channel Index (CCI) at 97.2 and Williams %R at -16.49. Momentum indicators show Day MACD at 3.88, Day MACD Signal Line at 3.54, DayATR at 3.07. Rate of Change indicators for Morepen Laboratories Ltd. include ROC125 at 45.04 and ROC21 at 25.3.
Exponential moving averages include EMA5 at ₹60, EMA10 at ₹58.6, EMA12 at ₹57.9, EMA20 at ₹55.5, EMA26 at ₹54, EMA50 at ₹50.1, EMA100 at ₹46.7, EMA200 at ₹46.7. Simple moving averages include SMA5 at ₹60.2, SMA10 at ₹59, SMA20 at ₹55, SMA30 at ₹51.7, SMA50 at ₹48.2, SMA100 at ₹44, SMA150 at ₹42.5, SMA200 at ₹43.9.
Support levels for Morepen Laboratories are placed at First Support ₹59.15, Second Support ₹57.33, Third Support ₹55.36. Resistance levels are seen at First Resistance ₹62.94, Second Resistance ₹64.91, Third Resistance ₹66.73. Morepen Laboratories Ltd. shareholding pattern shows promoter holding at 35.65%, FII holding at 1.59%, DII holding at 0%, public holding at 61.5%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 462.81 | 457.57 | 369.53 | 391.28 | 381.94 |
| Operating Expense | 439.50 | 415.68 | 341.60 | 372.33 | 351.78 |
| Operating Profit | 23.31 | 41.89 | 27.92 | 18.95 | 30.16 |
| Depreciation | 0.63 | 10.09 | 10.70 | 7.88 | 12.25 |
| Interest | 3.87 | 4.31 | 4.11 | 3.81 | 3.74 |
| Tax | 7.50 | 7.93 | 4.49 | 3.29 | 5.39 |
| Net Profit | 20.12 | 23.50 | 14.38 | 8.06 | 11.91 |
₹60.90
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 35.6 | 35.6 | 35.6 | 35.6 | 35.6 | 35.6 |
| FII | 2.2 | 1.9 | 1.7 | 1.6 | 1.6 | 1.6 |
| DII | 1.7 | 1.7 | 1.5 | 1.5 | 1.3 | 1.2 |
| Public | 60.5 | 60.7 | 61.1 | 61.2 | 61.5 | 61.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 49.23 L | 1.42 Cr | 34.71% |
| Week | 41.15 L | 1.22 Cr | 33.86% |
| 1 Month | 49.52 L | 1.78 Cr | 27.88% |
| 6 Month | 22.36 L | 85.2 L | 26.24% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Turnaround Potential (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Stock gained more than 20% in one month
RSI indicating price strength
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 Aug, 2025 | 0.2 | FINAL | 30 Aug, 2025 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹179.17 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -0.18% | -2.00% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.30 | 47.70 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 441 | 45.1 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy